中東およびアフリカの医薬品契約販売組織市場予測 2030 年 - 地域分析 - サービス (商用サービスおよび非商用サービス)、モジュール (シンジケート モジュールおよび専用モジュール)、治療領域 (心血管疾患、腫瘍学、代謝疾患、神経学、整形外科疾患、感染症など)、およびエンド ユーザー (バイオ医薬品会社および製薬会社) 別
新興市場の拡大が中東およびアフリカの医薬品契約販売組織市場を牽引
医薬品契約販売組織（CSO）市場の将来の軌道は、新興市場への拡大という戦略的傾向によって明確に形作られています。世界の医薬品業界の状況が拡大し、新興経済国が台頭するにつれて、CSOは未開発の可能性をますます認識するようになっています。新興市場では、医療意識の高まり、中流階級人口の拡大、医療インフラへの政府投資の増加によって、チャンスが生まれています。これらの急成長する市場に事業を拡大することで、CSOは医薬品に対する需要の高まりを活用し、大幅な成長が見込まれる市場に早い段階で強力な足場を築くことができます。ただし、この拡大には、現地の規制環境、文化的ニュアンス、多様な医療制度に関する賢明な理解が必要です。新興市場への拡大を成功させるには、CSO が各地域の固有の課題と機会に合わせて戦略を調整する必要がある、カスタマイズされたアプローチが必要です。さらに、このような拡大により、CSO はグローバルな医療エコシステムにおける重要なプレーヤーとしての地位を確立し、収益の増加と、これらの進化する市場での医療のアクセス性と成果を改善するというより広範な目標に貢献します。本質的に、新興市場での拡大に向けた戦略的動きは、グローバル化された医薬品環境の複雑さを乗り越える製薬 CSO の適応力と先見性を反映した、将来を見据えたトレンドとして浮上しています。
中東およびアフリカの医薬品契約販売組織市場の概要
中東およびアフリカの医薬品契約販売組織市場は、サウジアラビア、南アフリカ、UAE、およびその他の MEA に分割されています。市場の成長を促進する要因には、デジタル技術の統合の増加と、製品の販売を増やすことに対する製薬会社の関心の高まりが含まれます。ただし、アウトソーシングに関連する品質の問題が市場の成長を妨げています。 UAE は地域の先進国であり、そのヘルスケア部門は主に人口増加と医薬品需要の急増により著しい成長を遂げています。進歩的なヘルスケア部門は、製薬業界に重要な成長機会を提供します。UAE は世界で最も急速に成長している製薬産業の 1 つであり、高度な技術を採用していることでも知られています。ドバイ産業戦略 2030 やアブダビ ビジョン 2030 などのイニシアチブは、将来の成長見通し、輸出の可能性、中期から長期の経済的影響を考慮して、国の製薬部門の発展に重点を置いています。科学研究の大幅な進歩は、革新的な潜在的医薬品の開発と生産を促進します。製薬業界の激しい競争により、企業は市場のトップに留まるために、できるだけ早く治療薬を市場に投入することを余儀なくされています。このように、効率的な医薬品に対する需要の高まり、製薬会社の増加、感染症や慢性疾患の発生率の上昇、頻繁な製品発売は、中東およびアフリカにおける製薬業界の進歩を支え、それによってCSOサービスの使用が必要となり、それがこの地域の医薬品契約販売組織市場の成長に有利に働きます。
中東およびアフリカの医薬品契約販売組織市場の収益と2030年までの予測（百万米ドル）
中東およびアフリカの医薬品契約販売組織市場のセグメンテーション
中東およびアフリカの医薬品契約販売組織市場は、サービス、モジュール、治療領域、エンドユーザー、および国に分割されています。
サービスに基づいて、中東およびアフリカの医薬品契約販売組織市場は、商用サービスと非商用サービスに分かれています。商業サービスセグメントは、2022年に中東およびアフリカの医薬品契約販売組織市場で大きなシェアを占めました。
モジュールに基づいて、中東およびアフリカの医薬品契約販売組織市場は、シンジケートモジュールと専用モジュールに分かれています。シンジケートモジュールセグメントは、2022年に中東およびアフリカの医薬品契約販売組織市場で大きなシェアを占めました。
治療領域に基づいて、中東およびアフリカの医薬品契約販売組織市場は、心血管疾患、腫瘍学、代謝障害、神経学、整形外科疾患、感染症、その他に分類されています。腫瘍学セグメントは、2022年に中東およびアフリカの医薬品契約販売組織市場で最大のシェアを占めました。
エンドユーザーに基づいて、中東およびアフリカの医薬品契約販売組織市場は、バイオ医薬品会社と製薬会社に分かれています。製薬会社セグメントは、2022年に中東およびアフリカの医薬品契約販売組織市場で大きなシェアを占めました。
国に基づいて、中東およびアフリカの医薬品契約販売組織市場は、サウジアラビア、南アフリカ、UAE、およびその他の中東およびアフリカに分割されています。サウジアラビアは、2022年に中東およびアフリカの医薬品契約販売組織市場を支配しました。
Aenova Holding GmbH、IQVIA Holdings Inc、Pfizer Inc、およびSyneos Health Incは、中東およびアフリカの医薬品契約販売組織市場で事業を展開している大手企業の一部です。
Table of Content
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East & Africa PEST Analysis
5. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Integration of Digital Technologies
5.1.2 Growing Interest of Pharmaceutical Companies to Increase Sales of Products
5.2 Key Market Restraints
5.2.1 Quality Issues Associated with Outsourcing
5.3 Key Market Opportunities
5.3.1 Rising Use of Telemedicine and Remote Detailing
5.4 Key Future Trends
5.4.1 Expansion in Emerging Markets
5.5 Impact Analysis:
6. Pharmaceutical Contract Sales Organizations Market - Middle East & Africa Analysis
6.1 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
7. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Services
7.1 Overview
7.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
7.3 Commercial Services
7.3.1 Overview
7.3.2 Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Non-Commercial Services
7.4.1 Overview
7.4.2 Non-Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Modules
8.1 Overview
8.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
8.3 Syndicated Modules
8.3.1 Overview
8.3.2 Syndicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Dedicated Modules
8.4.1 Overview
8.4.2 Dedicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by Therapeutic Area
9.1 Overview
9.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
9.3 Cardiovascular Disorders
9.3.1 Overview
9.3.2 Cardiovascular Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Metabolic Disorders
9.5.1 Overview
9.5.2 Metabolic Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Neurology
9.6.1 Overview
9.6.2 Neurology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.7 Orthopaedic Diseases
9.7.1 Overview
9.7.2 Orthopedic Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.8 Infectious Diseases
9.8.1 Overview
9.8.2 Infectious Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 Others: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 - by End User
10.1 Overview
10.2 Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Biopharmaceutical Companies
10.3.1 Overview
10.3.2 Biopharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Pharmaceutical Companies
10.4.1 Overview
10.4.2 Pharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
11. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Country Analysis
11.1 Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Country
11.1.1 Saudi Arabia
11.1.1.1 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.1.2 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.1.3 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.1.4 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.1.5 Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.2 UAE
11.1.2.1 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.2.2 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.2.3 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.2.4 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.2.5 UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.3 South Africa
11.1.3.1 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.3.2 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.3.3 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.3.4 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.3.5 South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
11.1.4 Rest of Middle East & Africa
11.1.4.1 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
11.1.4.2 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services, 2020-2030 (US$ Million)
11.1.4.3 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules, 2020-2030 (US$ Million)
11.1.4.4 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area, 2020-2030 (US$ Million)
11.1.4.5 Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User, 2020-2030 (US$ Million)
12. Pharmaceutical Contract Sales Organizations Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies
12.2.1 Overview
13. Company Profiles
13.1 IQVIA Holdings Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Syneos Health Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Aenova Holding GmbH
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Pfizer Inc
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
14. Appendix
14.1 About Us
14.2 Glossary of Terms
?
List of Tables
Table 1. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Segmentation
Table 2. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 3. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 4. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 5. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 6. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 7. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 8. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 9. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 10. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 11. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 12. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 13. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Services - Revenue and Forecast to 2030 (US$ Million)
Table 15. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Modules - Revenue and Forecast to 2030 (US$ Million)
Table 16. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Therapeutic Area - Revenue and Forecast to 2030 (US$ Million)
Table 17. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 18. Recent Growth Strategies in the Pharmaceutical Contract Sales Organizations Market
Table 19. Glossary of Terms, Middle East & Africa Pharmaceutical Contract Sales Organizations Market
?
List of Figures
Figure 1. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Segmentation, By Country
Figure 2. Middle East & Africa - PEST Analysis
Figure 3. Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue (US$ Mn), 2022 - 2030
Figure 6. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Services, 2022 & 2030 (%)
Figure 7. Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Non-Commercial Services: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Modules 2022 & 2030 (%)
Figure 10. Syndicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Dedicated Modules: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by Therapeutic Area, 2022 & 2030 (%)
Figure 13. Cardiovascular Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Metabolic Disorders: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Neurology: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Orthopedic Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Diseases: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 21. Biopharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Pharmaceutical Companies: Middle East & Africa Pharmaceutical Contract Sales Organizations Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Middle East & Africa Pharmaceutical Contract Sales Organizations Market, by Key Country - Revenue, 2022 (US$ Million)
Figure 24. Middle East & Africa Pharmaceutical Contract Sales Organizations Market, By Key Countries, 2022 and 2030 (%)
Figure 25. Saudi Arabia: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 26. UAE: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. South Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Rest of Middle East & Africa: Middle East & Africa Pharmaceutical Contract Sales Organizations Market Revenue and Forecast to 2030 (US$ Mn)
1. Aenova Holding GmbH
2. IQVIA Holdings Inc
3. Pfizer Inc
4. Syneos Health Inc
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa Pharmaceutical Contract Sales Organizations Market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa Pharmaceutical Contract Sales Organizations Market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.